Sarah Schlesinger

Dr. Sarah J.
Schlesinger, MD, is an Independent Director at Armata Pharmaceuticals, Inc., a Lead Independent Director at Innoviva, Inc., an Associate Professor at The Rockefeller University, a Chairman at Rockefeller University Institutional Review Board, a Director-Education & Training at Rockefeller University Center For Clinical & Translational, a Member at American Association for the Advancement of Science, a Member at College of American Pathologists and a Member at United States & Canadian Academy of Pathology.
She is on the Board of Directors at Armata Pharmaceuticals, Inc., Innoviva, Inc., AIDS Vaccine Advocacy Coalition, Albert Einstein College of Medicine, Inc., eGenesis, Inc., Global Viral and The Hastings Center.
Dr. Schlesinger was previously employed as an Independent Director by The Medicines Co., an Independent Director by ARIAD Pharmaceuticals, Inc., a Member-Infectious & Parasitic Disease Pathology by Armed Forces Institute of Pathology, and a Chief Resident by NewYork-Presbyterian/Queens.
She also served on the board at Metabiota, Inc. She received her undergraduate degree from Wellesley College and a doctorate degree from Rush Medical College.